Advanced/Metastatic Tumors

1 clinical trials · Condition

Record	Firm	Date
Safety and Pharmacokinetics (PK) of Escalating Doses of Tiragolumab as a Single Agent and in Combination With Atezolizumab and/or Other Anti-Cancer Therapies in Locally Advanced or Metastatic Tumors (NCT02794571)	Genentech, Inc.	2016-05-23

Every clearance here is in the API, with alerts when new ones post.